PERCEPTIVE ADVISORS LLC – Alnylam Pharmaceuticals, Inc. Transaction History
PERCEPTIVE ADVISORS LLC portfolio value:
$0
portfolio value
PERCEPTIVE ADVISORS LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -172.99K shares | -25.23M | $200.16 | 0 |
| Q2 2022 | share | Decrease | -3.94% | -7.08K shares | -4.17M | $145.85 | 172.99K |
| Q1 2022 | share | Increase | 0.00% | 180.07K shares | 29.40M | $163.29 | 180.07K |
| Q1 2019 | share | Decrease | -100.00% | -262.24K shares | -18.46M | $93.45 | 0 |
| Q4 2018 | share | Decrease | -78.11% | -935.75K shares | -86.38M | $72.91 | 262.24K |
| Q3 2018 | share | Decrease | -35.14% | -648.91K shares | -77.05M | $87.52 | 1.19M |
| Q2 2018 | share | Increase | +44.20% | 566.10K shares | 29.35M | $98.49 | 1.84M |
| Q1 2018 | share | Decrease | -3.76% | -50K shares | -16.53M | $119.1 | 1.28M |
| Q4 2017 | share | Decrease | -25.60% | -458K shares | -41.08M | $127.05 | 1.33M |
| Q4 2017 | put | Decrease | -100.00% | -420K shares | -45K | $127.05 | 0 |
| Q4 2017 | call | Decrease | -100.00% | -100K shares | -2.31M | $127.05 | 0 |
| Q3 2017 | put | Increase | 0.00% | 420K shares | 45K | $117.49 | 420K |
| Q3 2017 | call | Increase | 0.00% | 100K shares | 2.31M | $117.49 | 100K |
| Q3 2017 | share | Decrease | -2.40% | -43.95K shares | 63.98M | $117.49 | 1.78M |
| Q2 2017 | share | Increase | +66.09% | 729.28K shares | 89.62M | $79.76 | 1.83M |
| Q1 2017 | share | Increase | +831.40% | 985K shares | 52.11M | $51.25 | 1.10M |
| Q4 2016 | share | Increase | 0.00% | 118.47K shares | 4.43M | $37.44 | 118.47K |